Shares in Botanix have dropped more than 40 per cent after the West Perth biotech announced a $45 million capital raising, but at a significant discount to its last traded price.

Shares in Botanix have dropped more than 40 per cent after the West Perth biotech announced a $45 million capital raising, but at a significant discount to its last traded price.